Biotech ETFs To Buy As Cancer Drug Breakthroughs Accelerate

Biotech companies have increasingly directed capital toward oncology treatments in recent years. The sector’s growth outlook may make this an interesting time to consider adding biotech exchange-traded funds (ETFs) to a diversified portfolio.